These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8416744)

  • 1. Immunoelectron microscopic localization of transforming growth factor beta 1 and latent transforming growth factor beta 1 binding protein in human gastrointestinal carcinomas: qualitative difference between cancer cells and stromal cells.
    Mizoi T; Ohtani H; Miyazono K; Miyazawa M; Matsuno S; Nagura H
    Cancer Res; 1993 Jan; 53(1):183-90. PubMed ID: 8416744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix-associated latent TGF-beta with latent TGF-beta binding protein in the progressive process in adriamycin-induced nephropathy.
    Tamaki K; Okuda S; Miyazono K; Nakayama M; Fujishima M
    Lab Invest; 1995 Jul; 73(1):81-9. PubMed ID: 7603044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta 1 and its latent form binding protein-1 associate with elastic fibres in human dermis: accumulation in actinic damage and absence in anetoderma.
    Karonen T; Jeskanen L; Keski-Oja J
    Br J Dermatol; 1997 Jul; 137(1):51-8. PubMed ID: 9274625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcellular localization of (latent) transforming growth factor beta and the latent TGF-beta binding protein in rat hepatocytes and hepatic stellate cells.
    Roth-Eichhorn S; Kühl K; Gressner AM
    Hepatology; 1998 Dec; 28(6):1588-96. PubMed ID: 9828223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced expression of transforming growth factor-beta s and transforming growth factor-beta type II receptor in the synovial tissues of patients with rheumatoid arthritis.
    Taketazu F; Kato M; Gobl A; Ichijo H; ten Dijke P; Itoh J; Kyogoku M; Rönnelid J; Miyazono K; Heldin CH
    Lab Invest; 1994 May; 70(5):620-30. PubMed ID: 8196359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical localization of basic fibroblast growth factor in carcinomas and inflammatory lesions of the human digestive tract.
    Ohtani H; Nakamura S; Watanabe Y; Mizoi T; Saku T; Nagura H
    Lab Invest; 1993 May; 68(5):520-7. PubMed ID: 8497125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of the latent transforming growth factor beta binding protein in malignant, but not benign prostatic tissue.
    Eklöv S; Funa K; Nordgren H; Olofsson A; Kanzaki T; Miyazono K; Nilsson S
    Cancer Res; 1993 Jul; 53(13):3193-7. PubMed ID: 7686449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the expression pattern of the latent transforming growth factor beta binding protein isoforms in normal and diseased human liver reveals a new splice variant missing the proteinase-sensitive hinge region.
    Michel K; Roth S; Trautwein C; Gong W; Flemming P; Gressner AM
    Hepatology; 1998 Jun; 27(6):1592-9. PubMed ID: 9620332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential deposition of latent TGF-beta binding proteins (LTBPs) during formation of the extracellular matrix in human lung fibroblasts.
    Koli K; Hyytiäinen M; Ryynänen MJ; Keski-Oja J
    Exp Cell Res; 2005 Nov; 310(2):370-82. PubMed ID: 16157329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of latent transforming growth factor-beta binding protein 1 (LTBP-1) in dioxin receptor-null mouse embryo fibroblasts.
    Santiago-Josefat B; Mulero-Navarro S; Dallas SL; Fernandez-Salguero PM
    J Cell Sci; 2004 Feb; 117(Pt 6):849-59. PubMed ID: 14762110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical localization of transforming growth factor-beta 1 in rats with experimental silicosis, alveolar type II hyperplasia, and lung cancer.
    Williams AO; Flanders KC; Saffiotti U
    Am J Pathol; 1993 Jun; 142(6):1831-40. PubMed ID: 8389528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Latent transforming growth factor binding protein 4 (LTBP-4) is downregulated in human mammary adenocarcinomas in vitro and in vivo.
    Mauel S; Kruse B; Etschmann B; von der Schulenburg AG; Schaerig M; Stövesand K; Wilcken B; Sterner-Kock A
    APMIS; 2007 Jun; 115(6):687-700. PubMed ID: 17550376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of the gene encoding the latent transforming growth factor-beta binding protein 4 (LTBP-4) causes abnormal lung development, cardiomyopathy, and colorectal cancer.
    Sterner-Kock A; Thorey IS; Koli K; Wempe F; Otte J; Bangsow T; Kuhlmeier K; Kirchner T; Jin S; Keski-Oja J; von Melchner H
    Genes Dev; 2002 Sep; 16(17):2264-73. PubMed ID: 12208849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and release of the latent transforming growth factor beta binding protein by hepatocytes from rat liver.
    Roth S; Schurek J; Gressner AM
    Hepatology; 1997 Jun; 25(6):1398-405. PubMed ID: 9185759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and matrix deposition of latent transforming growth factor beta binding proteins in normal and fibrotic rat liver and transdifferentiating hepatic stellate cells in culture.
    Breitkopf K; Lahme B; Tag CG; Gressner AM
    Hepatology; 2001 Feb; 33(2):387-96. PubMed ID: 11172340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Latent TGF-beta 1 binding protein (LTBP-1); a new marker for intra-and extraocular PEX deposits].
    Schlötzer-Schrehardt U; Küchle M; Hofmann-Rummelt C; Kaiser A; Kirchner T
    Klin Monbl Augenheilkd; 2000 Jun; 216(6):412-9. PubMed ID: 10919121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical localization of latent transforming growth factor-beta binding protein in IgA nephropathy.
    Wada T; Hamakawa S; Hori Y; Kaname S; Shimizu S; Kurokawa K; Katoh T
    Kidney Int Suppl; 1997 Dec; 63():S182-4. PubMed ID: 9407453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino acid requirements for formation of the TGF-beta-latent TGF-beta binding protein complexes.
    Chen Y; Ali T; Todorovic V; O'leary JM; Kristina Downing A; Rifkin DB
    J Mol Biol; 2005 Jan; 345(1):175-86. PubMed ID: 15567420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (Latent) transforming growth factor beta in liver parenchymal cells, its injury-dependent release, and paracrine effects on rat hepatic stellate cells.
    Roth S; Michel K; Gressner AM
    Hepatology; 1998 Apr; 27(4):1003-12. PubMed ID: 9537440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of transforming growth factor-beta in the formation of fibrotic lesions in carcinoid heart disease.
    Waltenberger J; Lundin L; Oberg K; Wilander E; Miyazono K; Heldin CH; Funa K
    Am J Pathol; 1993 Jan; 142(1):71-8. PubMed ID: 8424467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.